D. Dehertogh

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Deborah Dehertogh, D. Dehertogh, D Dehertogh, D A Dehertogh, Deborah A. Dehertogh
Publication record
28 papers · 3,620 citations · H-index 13

PAPERS

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.
20061,403 citationsauthor #12
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
20061,203 citationsauthor #7
Abstract Index
20040 citationsauthor #17
Development of Entecavir: Superior Therapy for the Management of Chronic Hepatitis B Viral Infection
20040 citationsauthor #1
Sustained viral load and ALT reduction following 48 weeks of entecavir treatment in HBEAG-negative and -positive patients with chronic hepatitis B who have failed prior lamivudine therapy
20038 citationsauthor #11
Baseline ALT level does not predict viral load reduction in response to Entecavir therapy
20035 citationsauthor #5
Summary of phase II clinical and laboratory safety experience with Entecavir
20033 citationsauthor #4
Corrigendum to “Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B” [J Hepatol 37 (2002) 137–144]
20021 citationsauthor #4
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.
2002299 citationsauthor #7
Sustained viral load and ALT reduction following 48 weeks of entecavir treatment in subjects with chronic hepatitis B who have failed lamivudine.
200238 citationsauthor #9
Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B.
200280 citationsauthor #4
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection
2001158 citationsauthor #11
Sorivudine versus Acyclovir for Treatment of Dermatomal Herpes Zoster in Human Immunodeficiency Virus-Infected Patients: Results from a Randomized, Controlled Clinical Trial
199846 citationsauthor #14
Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults. The Multinational Sorivudine Study Group.
199743 citationsauthor #10
Severe necrotizing soft-tissue infections: report of 22 cases.
199515 citationsauthor #2
Chronology of a hospital-wide measles outbreak: lessons learned and shared from an extraordinary week in late March 1989.
199215 citationsauthor #4
Recently acquired syphilis in the elderly population.
199212 citationsauthor #2
Rifampin‐Induced Immune Thrombocytopenia
198912 citationsauthor #2
Hypersensitivity reaction to bacillus Calmette-Guérin treated with plasmapheresis.
19899 citationsauthor #1
Rifampin-induced immune thrombocytopenia. A case report.
19897 citationsauthor #2
Hemorrhagic cystitis due to herpes simplex virus as a marker of disseminated herpes infection.
198820 citationsauthor #1
Carpal tunnel syndrome due to gonococcal tenosynovitis.
19885 citationsauthor #1
Hemorrhagic Cystitis Due to Herpes Simplex Virus as a Marker of Disseminated Herpes Infection
19880 citationsauthor #1
Legionella bozemanii and empyema.
19864 citationsauthor #2
Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients
198420 citationsauthor #4
Toxic-shock syndrome
19820 citationsauthor #1
Eubacterium tortuosum and Eubacterium ventriosum Bacteremia
19810 citationsauthor #1
Prednisone management of granulomatous mastitis.
1980212 citationsauthor #1

TIMELINE

1980 212 citations

1981 0 citations

1982 0 citations

1984 20 citations

1986 4 citations

1988 25 citations

1989 28 citations

1992 27 citations

1995 15 citations

1997 43 citations

1998 46 citations

2001 158 citations

2002 418 citations

2003 16 citations

2004 0 citations

2006 2,606 citations

D. Dehertogh

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT